BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu Y, Ehrich M, Fuhrman K, Zhang C. In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters. Nanoscale Res Lett 2014;9:434. [PMID: 25232295 DOI: 10.1186/1556-276X-9-434] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Z, Powers K, Hu Y, Raleigh M, Pentel P, Zhang C. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density. Biomaterials 2017;123:107-17. [PMID: 28167389 DOI: 10.1016/j.biomaterials.2017.01.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
2 Debele TA, Wu PC, Wei YF, Chuang JY, Chang KY, Tsai JH, Su WP. Transferrin Modified GSH Sensitive Hyaluronic Acid Derivative Micelle to Deliver HSP90 Inhibitors to Enhance the Therapeutic Efficacy of Brain Cancers. Cancers (Basel) 2021;13:2375. [PMID: 34069106 DOI: 10.3390/cancers13102375] [Reference Citation Analysis]
3 Grippin AJ, Sayour EJ, Mitchell DA. Translational nanoparticle engineering for cancer vaccines. Oncoimmunology 2017;6:e1290036. [PMID: 29123947 DOI: 10.1080/2162402X.2017.1290036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
4 Khademi F, Yousefi A, Derakhshan M, Najafi A, Tafaghodi M. Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration. Iran J Basic Med Sci 2019;22:893-900. [PMID: 31579445 DOI: 10.22038/ijbms.2019.33962.8079] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Cao S, Jiang Y, Levy CN, Hughes SM, Zhang H, Hladik F, Woodrow KA. Optimization and comparison of CD4-targeting lipid-polymer hybrid nanoparticles using different binding ligands. J Biomed Mater Res A 2018;106:1177-88. [PMID: 29271128 DOI: 10.1002/jbm.a.36315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hassan HA, Smyth L, Rubio N, Ratnasothy K, Wang JT, Bansal SS, Summers HD, Diebold SS, Lombardi G, Al-Jamal KT. Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo. J Control Release 2016;225:205-16. [PMID: 26802552 DOI: 10.1016/j.jconrel.2016.01.030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
7 Hu Y, Smith D, Frazier E, Hoerle R, Ehrich M, Zhang C. The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine. Biomaterials 2016;106:228-39. [PMID: 27569868 DOI: 10.1016/j.biomaterials.2016.08.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
8 Lv S, Sylvestre M, Prossnitz AN, Yang LF, Pun SH. Design of Polymeric Carriers for Intracellular Peptide Delivery in Oncology Applications. Chem Rev 2021;121:11653-98. [PMID: 33566580 DOI: 10.1021/acs.chemrev.0c00963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
9 Lou S, Zhao Z, Dezort M, Lohneis T, Zhang C. Multifunctional Nanosystem for Targeted and Controlled Delivery of Multiple Chemotherapeutic Agents for the Treatment of Drug-Resistant Breast Cancer. ACS Omega 2018;3:9210-9. [PMID: 30197996 DOI: 10.1021/acsomega.8b00949] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
10 Hu Y, Smith D, Zhao Z, Harmon T, Pentel PR, Ehrich M, Zhang C. Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine. Nanomedicine 2019;20:102023. [PMID: 31181264 DOI: 10.1016/j.nano.2019.102023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhao Z, Hu Y, Hoerle R, Devine M, Raleigh M, Pentel P, Zhang C. A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy. Nanomedicine 2017;13:443-54. [PMID: 27520729 DOI: 10.1016/j.nano.2016.07.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
12 Hu Y, Zhao Z, Ehrich M, Fuhrman K, Zhang C. In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles. Polymer (Guildf) 2015;80:171-9. [PMID: 26622069 DOI: 10.1016/j.polymer.2015.10.048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
13 Scopel R, Falcão MA, Cappellari AR, Morrone FB, Guterres SS, Cassel E, Kasko AM, Vargas RMF. Lipid-polymer hybrid nanoparticles as a targeted drug delivery system for melanoma treatment. International Journal of Polymeric Materials and Polymeric Biomaterials 2022;71:127-38. [DOI: 10.1080/00914037.2020.1809406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Babahosseini H, Srinivasaraghavan V, Zhao Z, Gillam F, Childress E, Strobl JS, Santos WL, Zhang C, Agah M. The impact of sphingosine kinase inhibitor-loaded nanoparticles on bioelectrical and biomechanical properties of cancer cells. Lab Chip 2016;16:188-98. [PMID: 26607223 DOI: 10.1039/c5lc01201e] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
15 Bose RJ, Arai Y, Ahn JC, Park H, Lee SH. Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery. Int J Nanomedicine 2015;10:5367-82. [PMID: 26379434 DOI: 10.2147/IJN.S87120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
16 Abdou EM, Fayed MAA, Helal D, Ahmed KA. Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats. Sci Rep 2019;9:19779. [PMID: 31875004 DOI: 10.1038/s41598-019-56320-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]